Spain · Delayed Price · Currency is EUR Naturhouse Health Statistics
Total Valuation
BME:NTH has a market cap or net worth of EUR 136.68 million. The enterprise value is 117.28 million.
| Market Cap | 136.68M |
| Enterprise Value | 117.28M |
Important Dates
The last earnings date was Friday, September 19, 2025.
| Earnings Date | Sep 19, 2025 |
| Ex-Dividend Date | Oct 22, 2025 |
Share Statistics
BME:NTH has 59.95 million shares outstanding.
| Current Share Class | 59.95M |
| Shares Outstanding | 59.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.27% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 14.25 and the forward PE ratio is 14.25.
| PE Ratio | 14.25 |
| Forward PE | 14.25 |
| PS Ratio | 2.86 |
| PB Ratio | 5.29 |
| P/TBV Ratio | 5.36 |
| P/FCF Ratio | 12.53 |
| P/OCF Ratio | 11.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.71, with an EV/FCF ratio of 10.75.
| EV / Earnings | 11.47 |
| EV / Sales | 2.45 |
| EV / EBITDA | 7.71 |
| EV / EBIT | 8.68 |
| EV / FCF | 10.75 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.12 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 0.36 |
| Interest Coverage | 22.65 |
Financial Efficiency
Return on equity (ROE) is 38.28% and return on invested capital (ROIC) is 26.55%.
| Return on Equity (ROE) | 38.28% |
| Return on Assets (ROA) | 17.74% |
| Return on Invested Capital (ROIC) | 26.55% |
| Return on Capital Employed (ROCE) | 44.21% |
| Revenue Per Employee | 259,832 |
| Profits Per Employee | 55,576 |
| Employee Count | 191 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 4.44 |
Taxes
In the past 12 months, BME:NTH has paid 3.47 million in taxes.
| Income Tax | 3.47M |
| Effective Tax Rate | 25.32% |
Stock Price Statistics
The stock price has increased by +36.53% in the last 52 weeks. The beta is 0.62, so BME:NTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +36.53% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 79.79 |
| Average Volume (20 Days) | 81,469 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NTH had revenue of EUR 47.81 million and earned 10.23 million in profits. Earnings per share was 0.16.
| Revenue | 47.81M |
| Gross Profit | 34.47M |
| Operating Income | 13.16M |
| Pretax Income | 13.69M |
| Net Income | 10.23M |
| EBITDA | 13.43M |
| EBIT | 13.16M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 23.34 million in cash and 3.94 million in debt, giving a net cash position of 19.41 million or 0.32 per share.
| Cash & Cash Equivalents | 23.34M |
| Total Debt | 3.94M |
| Net Cash | 19.41M |
| Net Cash Per Share | 0.32 |
| Equity (Book Value) | 25.84M |
| Book Value Per Share | 0.43 |
| Working Capital | 15.67M |
Cash Flow
In the last 12 months, operating cash flow was 11.64 million and capital expenditures -732,000, giving a free cash flow of 10.91 million.
| Operating Cash Flow | 11.64M |
| Capital Expenditures | -732,000 |
| Free Cash Flow | 10.91M |
| FCF Per Share | 0.18 |
Margins
Gross margin is 72.10%, with operating and profit margins of 27.52% and 21.39%.
| Gross Margin | 72.10% |
| Operating Margin | 27.52% |
| Pretax Margin | 28.64% |
| Profit Margin | 21.39% |
| EBITDA Margin | 28.10% |
| EBIT Margin | 27.52% |
| FCF Margin | 22.82% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 8.77%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 8.77% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 117.35% |
| Buyback Yield | n/a |
| Shareholder Yield | 8.85% |
| Earnings Yield | 7.48% |
| FCF Yield | 7.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:NTH has an Altman Z-Score of 6.03 and a Piotroski F-Score of 8.
| Altman Z-Score | 6.03 |
| Piotroski F-Score | 8 |